BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 38199049)

  • 1. Comparative characteristics of fatigue in irritable bowel syndrome and inflammatory bowel disease: A systematic review and meta-analysis.
    Kim YJ; Lee SG; Lee JS; Choi YJ; Son CG
    J Psychosom Res; 2024 Feb; 177():111589. PubMed ID: 38199049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis.
    Halpin SJ; Ford AC
    Am J Gastroenterol; 2012 Oct; 107(10):1474-82. PubMed ID: 22929759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presence of Irritable Bowel Syndrome Symptoms in Quiescent Inflammatory Bowel Disease Is Associated with High Rate of Anxiety and Depression.
    Perera LP; Radigan M; Guilday C; Banerjee I; Eastwood D; Babygirija R; Massey BT
    Dig Dis Sci; 2019 Jul; 64(7):1923-1928. PubMed ID: 30725303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.
    Abdalla MI; Sandler RS; Kappelman MD; Martin CF; Chen W; Anton K; Long MD
    Inflamm Bowel Dis; 2017 Feb; 23(2):325-331. PubMed ID: 28092305
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity.
    Diederen K; Hoekman DR; Hummel TZ; de Meij TG; Koot BG; Tabbers MM; Vlieger AM; Kindermann A; Benninga MA
    Aliment Pharmacol Ther; 2016 Jul; 44(2):181-8. PubMed ID: 27110920
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of comorbid depression between irritable bowel syndrome and inflammatory bowel disease: A meta-analysis of comparative studies.
    Geng Q; Zhang QE; Wang F; Zheng W; Ng CH; Ungvari GS; Wang G; Xiang YT
    J Affect Disord; 2018 Sep; 237():37-46. PubMed ID: 29758449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of biophenol-rich nutraceuticals in adults with inflammatory gastrointestinal diseases or irritable bowel syndrome: A systematic literature review and meta-analysis.
    Giang J; Lan X; Crichton M; Marx W; Marshall S
    Nutr Diet; 2022 Feb; 79(1):76-93. PubMed ID: 33960587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of geographic distributions of Irritable Bowel Syndrome with Inflammatory Bowel Disease fail to support common evolutionary roots: Irritable Bowel Syndrome and Inflammatory Bowel Diseases are not related by evolution.
    Szilagyi A; Xue X
    Med Hypotheses; 2018 Jan; 110():31-37. PubMed ID: 29317064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of irritable bowel syndrome-like symptoms using Rome IV criteria in patients with inactive inflammatory bowel disease and relation with quality of life.
    Ozer M; Bengi G; Colak R; Cengiz O; Akpinar H
    Medicine (Baltimore); 2020 May; 99(19):e20067. PubMed ID: 32384473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The central role of psychopathology and its association with disease severity in inflammatory bowel disease and irritable bowel syndrome.
    Piacentino D; Cesarini M; Badiali D; Pallotta N; Biondi M; Corazziari ES
    Riv Psichiatr; 2019; 54(2):75-83. PubMed ID: 30985832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease in remission: a systematic review and meta-analysis.
    Fairbrass KM; Costantino SJ; Gracie DJ; Ford AC
    Lancet Gastroenterol Hepatol; 2020 Dec; 5(12):1053-1062. PubMed ID: 33010814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Emotional and personality features of patients with irritable bowel syndrome and bowel inflammatory diseases].
    Mnatsakanyan MG; Dyukova GM; Pogromov AP; Tashchyan OV
    Klin Med (Mosk); 2016; 94(10):764-9. PubMed ID: 30299020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation.
    Waugh N; Cummins E; Royle P; Kandala NB; Shyangdan D; Arasaradnam R; Clar C; Johnston R
    Health Technol Assess; 2013 Nov; 17(55):xv-xix, 1-211. PubMed ID: 24286461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of metabolic syndrome in patients with inflammatory bowel disease: a systematic review and meta-analysis.
    Shen Z; Zhang M; Liu Y; Ge C; Lu Y; Shen H; Zhu L
    BMJ Open; 2024 Mar; 14(3):e074659. PubMed ID: 38453206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Calprotectin, IL-6, and CRP in Distinguishing Between Inflammatory Bowel Disease and Diarrhea Predominant Irritable Bowel Syndrome.
    Huong BT; Hien NM; Dung NT; Quang DM; Vinh NT; Tu TT; Chi TK; Phuong LB; Nhan NT
    Med Arch; 2024; 78(2):105-111. PubMed ID: 38566874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with longstanding ulcerative colitis in remission do not have more irritable bowel syndrome-like symptoms than controls.
    Lundgren D; Rutegård J; Eklöf V; Palmqvist R; Karling P
    BMC Gastroenterol; 2016 Nov; 16(1):139. PubMed ID: 27881072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of functional bowel symptoms on quality of life and fatigue in quiescent Crohn disease and irritable bowel syndrome.
    Piche T; Ducrotté P; Sabate JM; Coffin B; Zerbib F; Dapoigny M; Hua M; Marine-Barjoan E; Dainese R; Hébuterne X
    Neurogastroenterol Motil; 2010 Jun; 22(6):626-e174. PubMed ID: 20403099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Burden of Fatigue Among Patients with Ulcerative Colitis and Crohn's Disease: Results from a Global Survey of Patients and Gastroenterologists.
    Regueiro M; Hunter T; Lukanova R; Shan M; Wild R; Knight H; Bannikoppa P; Naegeli AN
    Adv Ther; 2023 Feb; 40(2):474-488. PubMed ID: 36370288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of functional dyspepsia-like symptoms in ulcerative colitis patients in clinical remission and overlap with irritable bowel syndrome-like symptoms.
    Kotani S; Fukuba N; Kawashima K; Mishima Y; Sonoyama H; Okimoto E; Tada Y; Oka A; Tamagawa Y; Oshima N; Mishiro T; Tobita H; Shibagaki K; Moriyama I; Ishimura N; Kushiyama Y; Fujishiro H; Ishihara S
    Scand J Gastroenterol; 2020 May; 55(5):560-564. PubMed ID: 32412797
    [No Abstract]   [Full Text] [Related]  

  • 20. Abdominal pain in patients with inflammatory bowel disease: association with single-nucleotide polymorphisms prevalent in irritable bowel syndrome and clinical management.
    Ledergerber M; Lang BM; Heinrich H; Biedermann L; Begré S; Zeitz J; Krupka N; Rickenbacher A; Turina M; Greuter T; Schreiner P; Roth R; Siebenhüner A; Vavricka SR; Rogler G; Beerenwinkel N; Misselwitz B;
    BMC Gastroenterol; 2021 Feb; 21(1):53. PubMed ID: 33546600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.